2021 annual financial data
Keros Therapeutics 2021 Operating margin
Direct answer
Operating margin was -280.46%.
Operating income was -56.37M USD and net income was -58.74M USD.
Operating cash flow was -62.15M USD.
Get free Keros Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 20.1M USD
- Operating income
- -56.37M USD
- Net income
- -58.74M USD
- Operating cash flow
- -62.15M USD